Editors' Pick Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study. Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, et al. JAMA Neurol. 2014 Feb 24. Epub 1969 Dec 31. PMID: 24566807. Abstract CommentRecommendBookmarkWatch